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ABSTRACT
The effect of recombinant bovine somatotropin
(bST) on the chemiluminescence, diapedesis, and ex-
pression of adhesion receptors (CD11a, CD11b,
CD18) of isolated polymorphonuclear leukocytes was
studied. The plasma concentrations of insulin-like
growth factor-I (IGF-I), bST, cortisol, and a-
lactalbumin were also monitored. In addition, general
and local clinical symptoms and the differentiation of
circulating leukocytes were also studied during ex-
perimentally induced Streptococcus uberis mastitis in
cows. Ten cows were infected with 500 cfu of S. uberis
O140J in both left quarters. Five cows were sub-
cutaneously treated with 500 mg of recombinant bST
7 d before and after infection, and 5 control cows
received the excipient. General (fever, tachycardia,
inappetance, and depression) and local symptoms
(swelling, pain, firmness, and flecks in milk) were
more acute, severe, and longer-lasting in control cows.
Treatment with bST had no effect on chemilumines-
cence and diapedesis of circulating polymorpho-
nuclear leukocytes and no effect on the expression of
adhesion receptors. Recombinant bST induced signifi-
cantly higher IGF-I and bST concentrations in
plasma. The leukopenia observed after infection was
less pronounced in the bST-treated cows, and the
number of circulating band neutrophils and metamye-
locytes was significantly lower in the treated group.
The concentration of cortisol did not differ between
both groups, but the blood concentration of a-
lactalbumin significantly increased in both groups
from 6 d after infection. These results showed that
treatment with recombinant bST improves animal
welfare by protecting the cows from severe local and
general clinical symptoms during subsequent S.
uberis mastitis, but that it has no effect on
chemiluminescence, diapedesis, and the expression of
adhesion receptors of circulating polymorphonuclear
leukocytes.
( Key words: Streptococcus uberis mastitis, recom-
binant bovine somatotropin, diapedesis, chemi-
luminescence)
Abbreviation key: AUC = area under the curve, CL
= chemiluminescence, DPBS = Dulbecco's PBS solu-
tion, HR = heart rate, MFI = mean fluorescence
intensity, PMA = phorbol 12-myristate 13-acetate,
PMN = polymorphonuclear leukocytes, RT = rectal
temperature, ST = somatotropin, TNF-a = tumor
necrosis factor alpha.
INTRODUCTION
Recombinant bST has been shown to protect cows
from excessive milk production losses and composi-
tional changes during a subsequent, experimentally
induced Escherichia coli and Streptococcus uberis
mastitis (25, 49). Recombinant bST also prevented
severe local and general clinical symptoms in cows
suffering from E. coli mastitis, especially in severe
responders. Indeed, cows that had been identified as
severe responders and previously treated with bST
reacted similarly to moderate responders treated with
the placebo. Prolactin, somatotropin ( ST) , and IGF-I
are thought to be involved in several immune func-
tions (13, 28, 30), and actions of bST can either be
direct or indirectly mediated through IGF-I. The
plasma and milk concentrations of IGF-I increase
after bST administration (5, 8, 38, 51, 56). Massart-
LeeÈn et al. (35) reported an increased number of
circulating leukocytes, band neutrophils, and an en-
hanced phorbol 12-myristate 13-acetate ( PMA) in-
duced respiratory burst activity in cows treated with
bST after calving. The generation of reactive oxygen
species, chemotaxis, random migration, phagocytosis
of IgG-opsonized microorganisms, and the PMA-
induced oxidative burst can be stimulated or primed
by IGF-I and ST (4, 10, 11, 19, 20, 29, 52, 53), and
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the expression of complement receptors can be up-
regulated. Increased chemotaxis and random migra-
tion (53), increased numbers of circulating neu-
trophils (7) , and increased proliferation of
granulocyte and monocyte precursors (36, 37, 44)
have also been observed following ST and IGF-I ele-
vations in vivo. Elvinger et al. (13) reported little or
no effect on phagocytosis and killing of E. coli by
circulating bovine polymorphonuclear leukocytes
( PMN) or on cytochrome c reduction in vitro as well
as in vivo. However, Heyneman et al. (22) observed
an increased oxidative burst after in vivo administra-
tion of bST in healthy cows.
Thus, there is ample evidence that bST and IGF-I
can modulate immune response of PMN. The purpose
of this study was to investigate whether previous
treatment with bST could reduce the severity of a
subsequent experimentally induced S. uberis mastitis
and whether the activity of circulating PMN could be
improved in cows previously treated with bST.
MATERIALS AND METHODS
Cows
Ten East Flemish Red Pied cows that were in their
first lactation, clinically healthy, and free of mastitis
were selected. At the start of the experiment, the cows
were between 6 and 15 wk postpartum. Before the
study began, the mammary glands of the cows were
examined clinically, and quarter milk samples were
examined bacteriologically. The SCC was determined.
Only those cows with an SCC lower than 2 × 105/ml
that were negative for major mastitis pathogens, such
as staphlococci and Gram-negative bacteria, were
selected for this study. Mean SCC before infection
was 47 × 103 ± 6 × 103/ml. During the experiment, the
cows were housed in individual tie stalls. Cows were
transferred to these stalls 1 wk before the start of the
experiment to allow acclimation. Cows were fed a
daily ration of approximately 8 kg of concentrate and
had ad libitum access to water and hay. Cows were
fed twice daily at 0630 and 1630 h, which did not
overlap with sampling or treatment. Cows were
milked twice daily at 0700 and 1700 h with a device
that measures individual mammary gland quarter
milk production. Mean milk production before the
first treatment with bST or the excipient (d ±7) was
16.8 ± 0.2 kg/d.
Inoculation Procedure
A phagocytosis-resistant S. uberis strain O140J
(James Leigh, Compton, UK) (32, 33) was main-
tained in a lyophilization medium at ±20°C. For ex-
perimental use, the bacteria were subcultured in
Todd Hewitt broth (Lab M, Bury, UK) at 37°C for 18
h. After washing, the organisms were resuspended
and diluted in pyrogen-free PBS. On d 0, 1 h after the
morning milking, the cows were inoculated in the left
front and left rear quarters with a suspension con-
taining approximately 500 cfu of S. uberis O140J in a
total volume of 20 ml of sterile pyrogen-free saline
solution per quarter. The bacterial suspension was
inoculated into the teat cistern using a sterile teat
cannula. Before inoculation, the teat ends were disin-
fected with 70% ethanol containing 0.5% chlorhexi-
dine. After the inoculation, each quarter was mas-
saged for 30 s to distribute the bacterial suspension in
the gland.
Experimental Design
All cows were experimentally infected with 500 cfu
of S. uberis at d 0 of the experiment. Bovine ST
treated-cows (n = 5) were injected subcutaneously
into the ischiorectal fossa with 500 mg of recombinant
bST (Posilac; Monsanto Co., St. Louis, MO) accord-
ing to label instructions 7 d before infection (d ±7)
and 7 d after infection (d +7). Similarly, the control
group (n = 5) was also subcutaneously injected with
excipient only on the same days. A mixture (Nafpen-
zal; Mycofarm Belga, Turnhout, Belgium) of sodium
nafcillin (100 mg), sodium penicillin G (300,000 U),
and dihydrostreptomycin sulfate (100 mg) was in-
jected once daily into the infected quarters of all cows
48 h after the first appearance of clinical symptoms.
This intramammary antibiotic treatment was con-
tinued for 3 consecutive d at 24-h intervals. The
experiment was divided into four different periods for
analyses: an 8-d period before the first bST treatment
(d ±7), a 7-d period between the first treatment and
infection (d 0), a 7-d period after the infection and
before the second treatment (d +7), and a 3-wk
period after the second treatment.
Clinical Investigation of Cows
Rectal temperature ( RT) and heart rate ( HR)
were recorded after the morning milking on d ±8, ±4,
and ±1 before infection. On the day of infection and on
d +1, +2, and +3, RT and HR were recorded at 0800,
1400, and 2000 h. On d +4, +5, +6, +7, +8, +9, +14,
+21, and +28, RT and HR were recorded once daily at
0800 h. Rumen motility was determined with a
stethoscope each time the HR was recorded. The
general behavior of the cows and their appetites were
also observed each time the HR was measured.
Journal of Dairy Science Vol. 82, No. 7, 1999
STREPTOCOCCUS UBERIS MASTITIS AND SOMATOTROPIN 1467
The mammary gland was clinically examined once
daily after the morning milking on d ±8, ±4, ±1, +4,
+6, +7, +8, +9, +14, +21, and +28. On d 0, +1, +2, and
+3, the mammary glands were examined at 0800,
1400, and 2000 h. Firmness, pain, and swelling were
monitored by palpation of the mammary gland, and
the appearance of the milk was also recorded.
Determination of Blood Parameters
Blood samples were collected once daily after the
morning milking on d ±8, ±4, ±1, +4, +6, +7, +8, +9,
+14, +21, and +28. On d 0, +1, +2, and +3, milk
samples were taken three times daily after the morn-
ing milking at 1400 and 2000 h.
Blood cortisol concentration was measured accord-
ing to the method of Eskola et al. (17) with the
DELFIA cortisol kit (Wallac Oy, Turku, Finland).
This assay is a solid-phase, time-resolved fluoroim-
munoassay based on the competitive reaction between
europium-labeled cortisol and sample cortisol for a
limited amount of binding sites on cortisol-specific,
biotinylated monoclonal antibodies.
Blood serum a-LA was measured essentially as
described by Akers et al. (2) . Highly purified bovine
a-LA (R. M. Akers, Virginia Polytechnic Institute and
State University, Blacksburg) was radioiodinated by
a chloramine-T procedure as described by Koprowski
and Tucker (31). Its specific activity was 104 to 115
mCi/mg, and approximately 0.2 ng of 125I-labeled a-LA
was added per tube. Antiserum was also provided by
R. M. Akers and was used at a final dilution of 1/
25,000 (vol/vol). Serum samples were assayed at fi-
nal dilutions of 1/20 (vol/vol) and 1/50 (vol/vol) (20
and 10 ml, respectively). In addition, some samples
that contained very high concentrations of a-LA were
reassayed at a dilution of 1/100 (vol/vol). Bound a-LA
was separated from free by second antibody (goat
anti-rabbit IgG; Linco Research Inc., St. Louis, MO)
precipitation. Intraassay and interassay coefficients
of variation were 9.5 and 12%, respectively.
Concentrations of IGF-I in plasma were measured
by radioimmunoassay according to the method previ-
ously described by Vicini et al. (51). Serum bST was
measured by radioimmunoassay using an antiserum
raised in rabbits (A/S batch R608-6/83; Monsanto
Co). Intraassay and interassay coefficients of varia-
tion were 12 and 6%, respectively.
The number of circulating leukocytes was counted
in an electronic cell counter (Coulter Counter ZF;
Coulter Electronics Ltd., Luton, UK). Differential
leukocyte counts were performed with a light micro-
scope on smears of 1 drop of whole blood stained with
eosin-giemsa (Hemacolor; E. Merck, Darmstadt,
Germany), by counting 100 cells. The number of the
different cell types in these 100 cells was expressed as
a percentage.
Isolation of PMN from Blood
Blood (40 ml) was aseptically collected from the
external jugular vein with evacuated tubes containing
heparin (6 IU/ml) as an anticoagulant (Laboratoire
EGA, Nogent±le Roi, France). The PMN were iso-
lated according to a method previously described
(27). Briefly, after the plasma layer was removed,
the buffy coat and the top layer of the packed red
blood cells were discarded. After a washing with 0.9%
NaCl, the remaining red blood cells were lysed by
adding 80 ml of double-distilled H2O and gently mix-
ing for 1 min. After restoration of isotonicity by the
addition of 40 ml of 2.7% NaCl and washing, the final
cell pellet was resuspended in 1 ml of Dulbecco's PBS
solution ( DPBS) . After isolation, the cells were
enumerated using an electronic cell counter (Coulter
Counter ZF). The viability of PMN immediately after
isolation was determined by trypan blue dye exclu-
sion, and differential cell counts were performed on
smears stained with eosin-giemsa (Hemacolor) . On
average, 70 to 95% of the isolated cells were PMN
with a viability of 97%. After counting and differen-
tiating the cells, cell suspensions for the
chemiluminescence ( CL) assay were adjusted to a
concentration of 5 × 106 viable PMN/ml in DPBS and
stored on ice until use. For the diapedesis assay, PMN
were suspended (107 PMN/ml) in Hanks balanced
salt solution containing 0.1% BSA.
CL Assay of Blood PMN
Luminol-dependent cellular CL was used to meas-
ure the respiratory burst activity of isolated PMN
according to the method previously described (26). A
stock solution (0.1 M in dimethyl sulfoxide) of lu-
minol (5-amino-2,3-dihydro-1,4-phthalazinedione;
Sigma Chemical Co., St. Louis, MO) was stored at
±20°C and, immediately before use, was thawed and
diluted to a concentration of 1 mM with DPBS. The
respiratory burst of the isolated bovine PMN was
activated by PMA (Sigma Chemical Co.) or by latex
beads (Serva Feinbiochemika and Co. GmbH KG,
Heidelberg, Germany) with a diameter of 0.7 to 0.8
mm. A stock solution of PMA was prepared by dissolv-
ing 200 mg in 1 ml of dimethyl sulfoxide and storing at
±20°C. The ratio of PMN to latex beads was about 1:3.
The CL assay was performed at 37°C with a
microtiterplate luminometer (LB96P; EG&G Ber-
thold GmbH, Bad Wildbad, Germany). The total
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volume used in the wells was 200 ml. The CL response
was registered in duplicate for 30 min at 37°C after
adding DPBS, 0.3 mM luminol, and 200 ng/ml of PMA
or a suspension of 20 × 106 latex beads to the cell
suspension (final concentration of 2 × 106 cells/ml).
The area under the curve ( AUC) was calculated for
the registered impulse rates (counts per minute) over
the entire 30-min measurement period.
The CL response was expressed as AUC over the
30-min measurement period. Not only the total
response of all isolated cells, of which between 70 and
95% were PMN, was used for statistical analysis, but
also the response corrected for the real number of
neutrophils in each sample of isolated cells. Correc-
tions were made by first expressing the CL response
per 1000 PMN in the sample and consequently by
correcting for the percentage of eosinophils in the
sample by arbitrarily accepting that the CL response
of eosinophils is five times higher than that of neu-















In this formula, T = CL response, PMN = percentage
of PMN in the isolated cell suspension, N = percen-
tage of neutrophils, and E = percentage of eosinophils.
For statistical analyses, the AUC of the data, ex-
pressed as the AUC per 24 h, of the total CL response
was calculated over seven time periods, one preinfec-
tion period, and six postinfection periods. Similarly,
the AUC of the corrected CL data was calculated over
seven time periods, one preinfection period, and six
postinfection periods. All AUC were logarithmically
transformed before analysis.
Cell Culture of Mammary Epithelial Cells
and Diapedesis Assay
The system for culture of bovine mammary
epithelial cells was developed according to the method
previously described by Smits et al. (45, 46). Briefly,
membrane inserts with a diameter of 12 mm and a
pore size of 12 mm (Millicell-PCF; Millipore, Bedford,
MA) were coated with collagen by immersion in wells
of 24-well plates (Nunc, Roskilde, Denmark) contain-
ing 1% calf skin collagen type I solution (Sigma
Chemical Co.) and incubated for 48 h at 4°C. These
inserts were then inverted in 6-well plates (Nunc)
containing culture medium as described previously
(45, 46). After adding bovine primary secretory eip-
thelial cells (3 × 105 per insert), the inserts were
incubated for 7 d at 37°C in an atmosphere containing
5% CO2 in air. Confluence of the epithelial monolayer
was tested by measurement of the transepithelial
electrical resistance using an ohmmeter (Millipore).
Only monolayers with a resistance of >1000 V/cm2
were used for further experiments (45, 46).
The diapedesis assay was performed as previously
described by Smits et al. (45, 46). Bovine PMN were
isolated and suspended in Hanks balanced salt solu-
tion containing 0.1% BSA at a concentration of 1 ×
107 cells/ml. Epithelial monolayers were rinsed exten-
sively in Hanks balanced salt solution to remove me-
dia and residual serum components. The isolated
PMN were added to the upper chamber of the inserts
(basal side of the secretory cells). Purified bovine
C5a-des-Arg (P. Rainard, Laboratoire de Pathologie
Infectieuse et d'Immunologie, Institut National de la
Recherche Agronomique, Nouzilly, France) was ad-
ded to the lower chamber of the inserts (50 ng/ml of
medium, apical side of the cells). Five hours after
incubation at 37°C in an atmosphere with 5% CO2 in
air, the number of PMN undergoing diapedesis was
counted in 50 ml of the apical medium (lower cham-
ber) using a hemocytometer. Isolated blood PMN
from each cow were assayed in duplicate, and results
were averaged.
Flow Cytometric Analysis
of Bovine Adhesion Receptors
Blood samples (6 ml), collected aseptically in 4 ml
of Alsever solution (Gibco BRL, Life Technologies
Inc., Gaithersburg, MD), were incubated for 15 min
at room temperature (20°C) with 50 ml of monoclonal
antibody to bovine CD11a (IL-A99; International
Livestock Research Institute, Nairobi, Kenya), bovine
CD11b (IL-A15; International Livestock Research In-
stitute), and bovine CD18 (MF14B4; FUNDP,
Namur, Belgium) or with RPMI 1640 medium (Gibco
BRL). After this incubation, red blood cells were
lysed with ice-cold sterile buffer solution (0.02 M
Tris´hydroxymethyl-aminomethane and 0.14 M
NH4Cl in H2O). After centrifugation (200 × g, 10
min, 4°C), the leukocytes were washed twice in RPMI
1640 medium followed by an incubation with a secon-
dary antibody solution (50 ml of goat anti-mouse IgG
conjugated with fluorescein isothiocyanate; Sigma
Chemical Co.) for 30 min on ice in the dark. After
centrifugation (200 × g, 10 min, 4°C), the cells were
washed twice with PBS, and the cell pellet was fixed
by addition of 0.1 ml of paraformaldehyde (1%) in
PBS and stored at 4°C until analysis.
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Figure 1. Changes in rectal temperature (RT) of recombinant
bST-treated cows ( Ú) and control cows ( ×) during experimentally
induced Streptococcus uberis mastitis. Data are means of five cows,
and error bars represent the standard errors of the means. Periods:
±1 = preinfection, 0 = 0 to 24 h after infection, 1 = 30 to 48 h after
infection, 2 = 54 to 72 h after infection, 3 = 78 to 96 h after infection,
4 = 120 to 156 h after infection, 5 = d +7 to +9, and 6 = d +14 to +28.
The expression of the bovine CD11a, CD11b, and
CD18 adhesion receptors was estimated by flow
cytometry (FACScan; Becton Dickinson Im-
munocytometry Systems, San Jose, CA) at an excita-
tion wavelength of 488 nm and emission wavelengths
of 530 and 560 nm. The PMN were selectively gated
for analysis by forward scatter (size) and side scatter
(granularity). The mean fluorescence intensity
( MFI) of the PMN gated in the forward scatter-side
dot plot was used to quantify the expression of adhe-
sion receptors. The fluorescence of PMN incubated
with the secondary antibody but without the primary
antibodies to CD11a, CD11b, and CD18 was used as
the control for nonspecific fluorescence, which was
subtracted from the fluorescence of the primary anti-
body incubated with PMN.
Statistical Analyses
Means, standard deviations, and standard errors of
the means were calculated using Statistix (47).
Statistical analysis of all data was performed using
an ANOVA (mixed linear model) with the following
model: Y = m + T + t + C/T + Intl + Int2 + e, where Y =
dependent variable, m = overall mean, T = treatment,
t = time, C/T = cow nested within treatment, Int1 =
interaction between treatment and time (T × t), and
Int2 = interaction between the cows nested within the
treatment and time (C/T × t), and e is the experimen-
tal error term. Treatment and time were fixed varia-
bles, and individual cows were randomized variables,
which were nested within the treatment. To study the
effects of treatment, the error term was C/T. To study
the effects of time, the Int2 term was the error term.
After running the ANOVA, general contrasts were
calculated. Significant differences were determined at
P < 0.05, P < 0.01, and P < 0.001.
RESULTS
General Clinical Symptoms, RT, and HR
Until 12 h postinfection, no marked clinical symp-
toms were apparent. Loss of appetite, tachypnea, and
general depression were only observed in some control
cows, but rumen motility was not affected. Rectal
temperature of all cows showed multiple peaks during
8 d in the control cows (40.3 ± 0.14°C) and during 2
to 3 d in the treated cows (39.4 ± 0.19°C) (Figure 1).
One treated cow showed a RT >40°C, but all control
cows had RT >40°C, and two control cows had RT
>41°C. Rectal temperature reached the first peak af-
ter 24 h in the treated group ( P < 0.05) and the
control group ( P < 0.001) and the second peak after
84 h in the control group ( P < 0.01). On d +5, RT
started to decrease again ( P < 0.01), but was still
higher ( P < 0.01) than before infection. From d +7,
the RT became normal again in the control cows, and,
from 3 d after infection, the RT became normal again
in the treated cows. In the treated cows, no changes
( P > 0.05) in the HR could be observed during the
entire experiment (Figure 2). From 24 h after infec-
tion, control cows showed tachycardia with HR higher
( P < 0.001) than before infection. On d +3 HR
decreased slightly but remained higher ( P < 0.05)
than those before infection. Tachycardia continued in
control cows until about 10 d after infection. The HR
of the control cows was higher ( P < 0.001) than that
of the treated cows during the entire postinfection
period.
Local Clinical Symptoms
About 6 h after infection, milk leakage was ob-
served in the infected and contralateral quarters of 1
cow in each group. Mastitis symptoms became appar-
ent after 24 h postinfection. The infected quarters
were swollen and painful, and firmness was slightly
increased. From 30 h postinfection, these symptoms
became more prominent, and small flecks appeared in
the milk of control cows. Most prominent symptoms
Journal of Dairy Science Vol. 82, No. 7, 1999
HOEBEN ET AL.1470
Figure 2. Changes in heart rate (HR) of recombinant bST-
treated cows ( Ú) and control cows ( ×) during experimentally in-
duced Streptococcus uberis mastitis. Data are means of five cows
and error bars represent the standard errors of the means. Periods:
±1 = preinfection, 0 = 0 to 24 h after infection, 1 = 30 to 48 h after
infection, 2 = 54 to 72 h after infection, 3 = 78 to 96 h after infection,
4 = d +6 to +9, and 5 = d +14 to +28.
Figure 3. Chemiluminescence (CL) of the total isolated leuko-
cyte population of recombinant bST-treated cows ( Ú) and control
cows ( ×) during experimentally induced Streptococcus uberis
mastitis after stimulation by phorbol 12-myristate 13-acetate ( A )
and latex beads (B). Data are means of the logarithmic transfor-
mation of the areas under the curves (AUC) of different periods for
five cows, and error bars represent the standard errors of the
means. Periods: ±1 = preinfection, 0 = 0 to 24 h after infection, 1 =
24 to 48 h after infection, 2 = 48 to 72 h after infection, 3 = 72 to 84
h after infection, 4 = 84 to 216 h after infection, and 5 = d +9 to +28.
were observed in 3 control cows and 1 treated cow. On
d +3, the firmness, pain, and number of milk flecks
increased in these cows, and the milk of the control
cow with the most severe symptoms becoming watery
and yellow. On d +4, local symptoms and the number
of flecks further increased. All control cows and only 2
treated cows showed marked symptoms. On d +6, the
glands of all control cows and 3 treated cows were
very painful, swollen, and firm, and many flecks were
present. The milk of 3 control cows and 1 treated cow
became reddish. On d +9, the symptoms began to
abate in most cows. Two weeks after infection, the
health of the mammary gland of all cows, except 1
control cow, was markedly improved. At d +28, the
infected quarters of some cows were still swollen and
harder than before infection.
CL
The total CL response after stimulation of leuko-
cytes by PMA slightly decreased ( P < 0.05) in the
control group between 24 and 48 h after infection
(Figure 3A). Between 48 and 72 h after infection, CL
was normalized, but between 72 and 84 h after infec-
tion, the response decreased in both the control ( P <
0.01) and the treated group ( P < 0.001). Thereafter,
CL response increased ( P < 0.001) in both groups.
From d +9, the total CL response continued to in-
crease ( P < 0.01) in the treated group and reached
levels higher than those observed before infection ( P
< 0.001) in both groups.
The total CL response of leukocytes stimulated by
latex increased ( P < 0.01) in the treated group be-
tween 0 and 24 h after infection (Figure 3B). Be-
tween 48 and 72 h after infection, CL further in-
creased ( P < 0.05) in the treated group, but was still
comparable to preinfection levels in the control cows.
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Figure 4. Corrected chemiluminescence (CL) of the isolated
neutrophils of recombinant bST-treated cows ( Ú) and control cows
( ×) during experimentally induced Streptococcus uberis mastitis
after stimulation by phorbol 12-myristate 13-acetate ( A ) and latex
beads (B). Data are means of the logarythmic transformation of
the areas under the curves (AUC) of different periods for five cows,
and error bars represent the standard errors of the means. Periods:
±1 = preinfection, 0 = 0 to 24 h after infection, 1 = 24 to 48 h after
infection, 2 = 48 to 72 h after infection, 3 = 72 to 84 h after infection,
4 = 84 to 216 h after infection, and 5 = d +9 to +28.
Between 72 and 84 h after infection, the CL response
decreased in the treated ( P < 0.01) and the control ( P
> 0.05) group toward preinfection values. In the
period between d +3 and +9, CL increased ( P < 0.01)
in both groups to values that were higher ( P < 0.01)
than the preinfection values. From d +9, the total CL
response after stimulation with latex beads was still
higher than the preinfection response in the treated
( P < 0.001) and control ( P < 0.05) group.
The corrected CL response (Figure 4A) of the iso-
lated neutrophils after stimulation by PMA did not
change ( P > 0.05) during the first 48 h after infection
in either group. Between 48 and 72 h after infection,
CL increased ( P < 0.05) in the control group. From d
+4 onward, the CL response started to increase ( P >
0.05) in both groups toward values that were higher
( P < 0.05) than the preinfection values in the treated
cows. There were no differences between control and
treated groups in any of the periods.
The corrected CL response of the isolated neu-
trophils after stimulation by latex beads (Figure 4B).
Between 48 and 72 h after infection, CL increased ( P
< 0.05) in the treated group, but returned ( P < 0.01)
to normal values between 72 and 84 h after infection.
Between d +3 and +9, the CL response in the control
cows was higher ( P < 0.05) than the preinfection
response, but returned to preinfection values from d
+9. From d +3, the CL response in the treated group
was higher ( P < 0.01) than the preinfection CL
response.
Diapedesis
At d +21 after infection, the percentage of PMN
undergoing diapedesis was higher ( P < 0.05) in the
control cows than in treated cows (Figure 5), but no
differences between both groups were observable on
any other day. During the first 24 h postinfection,
diapedesis decreased ( P < 0.05) by 83 and 80% in the
treated and control groups, respectively. Normal
baseline values were reached by the end of the study
(d +28).
Expression of Adhesion Receptors
The expression of CD11a on circulating PMN for
control and treated cows did not differ ( P > 0.05)
during the entire experiment (Figure 6). Between 24
and 48 h postinfection, MFI for CD11a decreased ( P <
0.01) by 15% in the control group, which was the
lowest MFI between 36 and 48 h postchallenge. From
60 h postinfection, the expression of CD11a started to
increase ( P < 0.05) in the control group, and baseline
values were reached between d +4 and +6. In the
treated cows, no changes were observed.
The expression of CD11b was higher ( P < 0.05) in
the control cows than in the treated cows between 24
and 48 h after infection (Figure 7). The MFI for
CD11b in the control group ( P < 0.05) increased by
15% to a maximum between 36 and 48 h after
challenge and then gradually decreased. The MFI was
reduced by 15 and 13% ( P < 0.01; d +6 and +9) and
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Figure 5. Percentage of polymorphonuclear leukocytes (PMN)
undergoing diapedesis isolated from blood of recombinant bST-
treated cows ( Ú) and control cows ( ×) during experimentally in-
duced Streptococcus uberis mastitis. Data are means of five cows,
and error bars represent the standard errors of the means.
Figure 6. Expression of CD11a on polymorphonuclear leukocytes
isolated from blood of recombinant bST-treated cows ( Ú) and con-
trol cows ( ×) during experimentally induced Streptococcus uberis
mastitis. Data are means of the mean fluorescence intensities
(MFI) of five cows, and error bars represent the standard errors of
the means. Periods: ±1 = preinfection, 0 = 12 to 24 h after infection,
1 = 36 to 48 h after infection, 2 = 60 to 72 h after infection, 3 = 84 to
144 h after infection, 4 = d +7 to +9, and 5 = d +14 to +28.
Figure 7. Expression of CD11b on polymorphonuclear leukocytes
isolated from blood of recombinant bST-treated cows ( Ú) and con-
trol cows ( ×) during experimentally induced Streptococcus uberis
mastitis. Data are means of the mean fluorescence intensities
(MFI) of five cows, and error bars represent the standard errors of
the means. Periods: ±1 = preinfection, 0 = 12 to 24 h after infection,
1 = 36 to 48 h after infection, 2 = 60 to 72 h after infection, 3 = 84 to
144 h after infection, 4 = d +7 to +9, and 5 = d +14 to +28.
by 28 and 27% ( P < 0.001; d +14 to +28) for the
control and treated groups, respectively.
Between 60 and 72 h postchallenge (Figure 8),
treated cows showed a higher ( P < 0.05) MFI for
CD18 than did control cows because of an increase ( P
< 0.01) of the MFI for CD18 in the treated cows. In
the control cows, no changes ( P > 0.05) in the expres-
sion of CD18 on PMN were observed. If the first 72 h
postinfection are studied in detail for both groups
(data not shown), an increase ( P < 0.001) was ob-
served at 24 h postinfection, followed by a decrease
between 36 and 48 h, and a second increase ( P <
0.01) at 60 h. Baseline values were reached by d +4.
Blood IGF-I
The concentration of IGF-I in the plasma of the
treated cows was higher ( P < 0.001) from the first
treatment until d +14 (Figure 9) compared with the
concentration in the control cows. After the first bST
treatment, IGF-I increased by approximately 97% ( P
< 0.01) before infection and continued to increase ( P
< 0.05) during the first 24 h after infection. From 24
h postinfection, IGF-I gradually decreased ( P < 0.01).
Between d +6 and +9, concentrations similar to those
observed before the first treatment were reached. Af-
ter the second bST treatment, IGF-I increased by
approximately 73% and reached a maximum 1 wk
after this treatment (d +14). After this second peak,
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Figure 8. Expression of CD18 on polymorphonuclear leukocytes
isolated from blood of recombinant bST-treated cows ( Ú) and con-
trol cows ( ×) during experimentally induced Streptococcus uberis
mastitis. Data are means of the mean fluorescence intensities
(MFI) of five cows, and error bars represent the standard errors of
the means. Periods: ±1 = preinfection, 0 = 12 to 24 h after infection,
1 = 36 to 48 h after infection, 2 = 60 to 72 h after infection, 3 = 84 to
144 h after infection, 4 = d +7 to +9, and 5 = d +14 to +28.
Figure 9. Concentration of IGF-I in plasma of recombinant bST-
treated cows ( Ú) and control cows ( ×) during experimentally in-
duced Streptococcus uberis mastitis. Data are means of five cows,
and error bars represent the standard errors of the means. Periods:
±2 = day ±8, ±1 = day ±4 to the hour of infection, 0 = 6 to 24 h after
infection, 4 = d +6 to +8, 5 = d +9 to +14, and 6 = d +21 to +28.
IGF-I decreased ( P < 0.001) toward concentrations
that were similar to those before the first treatment.
The IGF-I response after the first and second bST
treatment did not differ ( P > 0.05).
In the control cows, IGF-I decreased ( P < 0.05) by
40% from d +2. In the most severely diseased cow, a
decrease of 86% was observed. The concentration re-
mained lower ( P < 0.05) until 72 h after infection.
From that moment on, IGF-I began to increase again
to reach concentrations similar to preinfection concen-
trations.
Blood bST
A pattern similar to IGF-I was observed (Figure
10). As expected, the concentration of bST was higher
( P < 0.001) in bST-treated cows than in control cows
during the entire experiment. However, prior to injec-
tion, treated cows also had higher ( P < 0.01) plasma
bST concentrations than did controls. After the first
bST treatment, an increase of 34% in bST concentra-
tions was observed. From 24 h after infection, bST
gradually decreased and reached pretreatment values
from d +4. After the second treatment, bST increased
by 31% ( P < 0.01) followed by a decrease toward
concentrations that were similar to those before the
first treatment from d +21 to +28. The concentration
after the first treatment was 23% higher ( P < 0.01)
than the concentration after the second bST treat-
ment. In the control cows, no changes ( P > 0.05) in
the concentration of bST in plasma were observed.
Leukocyte Counts and Differentiation
In the control cows, the number of circulating leu-
kocytes decreased ( P < 0.01) by 24% between 30 and
48 h after infection (Figure 11). The number of cir-
culating leukocytes reached its lowest value between
48 and 72 h postinfection and was 37% lower than the
preinfection number. In the most severely diseased
cow, a decrease of 70% was observed. Beginning 72 h
after infection, the number of circulating leukocytes
started to increase until, between d +14 and +28,
normal numbers of circulating leukocytes were
present. Between 54 and 72 h after infection, a differ-
ence (27%; P < 0.05) in the numbers of circulating
leukocytes was observed between both groups. The
decrease ( P > 0.05) in the number of circulating
leukocytes of the treated cows was less pronounced
than that of the control cows.
The number of circulating lymphocytes was similar
in both groups during the entire experiment (Figure
12A). From 30 h after infection, the number of lym-
phocytes decreased by 25% ( P < 0.05) in the treated
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Figure 10. Concentration of bST in plasma of recombinant bST-
treated cows ( Ú) and control cows ( ×) during experimentally in-
duced Streptococcus uberis mastitis. Data are means of five cows,
and error bars represent the standard errors of the means. Periods:
±2 = day ±8, ±1 = day ±4 to hour of infection, 0 = 6 to 24 h after
infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection,
3 = 78 to 96 h after infection, 4 = d +6 to +7, 5 = d +8 to +14, and 6 =
d +21 to +28.
Figure 11. Changes in the number of circulating leukocytes
(WBC) of recombinant bST-treated cows ( Ú) and control cows ( ×)
during experimentally induced Streptococcus uberis mastitis. Data
are means of five cows, and error bars represent the standard
errors of the means. Periods: ±1 = preinfection, 0 = 6 to 24 h after
infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection,
3 = 78 to 96 h after infection, 4 = d +6 to +9, and 5 = d +14 to +28.
cows and by 38% ( P < 0.01) in the control cows. In
the most severely diseased cow, a decrease of 60%
was observed. From 72 h, the number of lymphocytes
started to increase. The percentage of circulating lym-
phocytes in the treated group decreased from 63 ± 2.8
to 51.9 ± 2.7% between 30 and 48 h after infection,
but the percentage increased from d 14 to +28 to 64.5
+ 5.5%. In the control group, a decrease from 62.8 ±
1.7 to 54.1 ± 2.5% was observed between 30 and 48 h
after infection followed by an increase to 63.1 ± 2.8%
between d +14 and +28.
Between 48 and 72 h after infection, the number of
circulating mature neutrophils was higher (63%; P <
0.05) in the treated cows than in the control cows
(Figure 12B) but did not change in either group
during the entire study. However, in the most se-
verely diseased cow, a decrease of 89% was observed.
The percentage of circulating mature neutrophils in
the treated cows increased from 33 ± 2.6 to 42.5 ±
3.3% between 30 and 48 h postinfection followed by a
decrease to 31.7 ± 4.7%. In the control cows, an in-
crease from 34.5 ± 1.7 to 40.3 ± 3.1% was observed
during the same period, followed by a decrease to 34.4
± 2.6%.
On d 0, the number of circulating eosinophils was
higher ( P < 0.01) in the treated cows (Figure 12C).
No changes ( P > 0.05) in the number and the percen-
tage of circulating eosinophils could be observed in
either of the groups.
The number of circulating monocytes was higher
( P < 0.05) in the control cows than in the treated
cows between 0 and 48 h postinfection (Figure 12D)
and increased ( P < 0.01) in the control cows on d 0.
From 54 h, the number of monocytes decreased to
values similar to preinfection numbers. The percen-
tage of circulating monocytes showed a similar pat-
tern.
In both groups, band neutrophils appeared in the
circulation of all cows at 24 h (Figure 12E). Between
78 and 96 h after infection, the number of circulating
band neutrophils was higher ( P < 0.05) in the control
group than in the control group. An increase ( P <
0.05) occurred in both groups on d 0 followed by a
decrease between 54 and 72 h after infection. Be-
tween d +6 and +9, an increase was observed in the
treated cows but not in the control cows. Between d
+14 and +28, the number of band neutrophils was
reduced to normal levels again. The percentage of
circulating band neutrophils followed the same pat-
tern.
The number of circulating metamyelocytes was
higher ( P < 0.05) in the control cows than in the
treated cows between 78 and 96 h postinfection
(Figure 12F). Metamyelocytes appeared in the circu-
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Figure 12. Changes in the number of circulating lymphocytes (A), mature neutrophils (B), eosinophils (C), monocytes (D), band
neutrophils (E), and metamyelocytes ( F ) of recombinant bST-treated cows ( Ú) and control cows ( ×) during experimentally induced
Streptococcus uberis mastitis. Data are means of five cows, and error bars represent the standard errors of the means. Periods ±1 =
preinfection, 0 = 6 to 24 h after infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection, 3 = 78 to 96 h after infection, 4 = d +6
to +9, and 5 = d +14 to +28.
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Figure 13. Changes in the percentage of circulating mature
neutrophils ( Ú) , band neutrophils ( „) and metamyelocytes ( Ø) of
the total neutrophilic population in blood of recombinant bST-
treated cows ( A ) and control cows ( B ) during experimentally
induced Streptococcus uberis mastitis. Data are means of five cows,
and error bars represent the standard errors of the means. Periods:
±1 = preinfection, 0 = 6 to 24 h after infection, 1 = 30 to 48 h after
infection, 2 = 54 to 72 h after infection, 3 = 78 to 96 h after infection,
4 = d +6 to +9, and 5 = d +14 to +28.
lation of 1 treated cow and 5 control cows and disap-
peared after d +6. The percentage of circulating
metamyelocytes followed the same pattern as the ab-
solute number.
The percentage of mature neutrophils in the total
neutrophil population differed ( P < 0.01) between
both groups from 72 to 96 h after infection (Figure
13, A and B). The decrease occurred earlier and was
more pronounced in the control cows. On d +3, control
cows had a higher percentage (2.2 ± 1.35 vs. 11 ±
5.7%; P < 0.01) of immature band neutrophils in the
circulation than did treated cows. The increase in
band neutrophils was more pronounced and longer
lasting in the control cows. In the most severely ill
cow, approximately 32% of the neutrophil population
was band neutrophils. The percentage of metamyelo-
cytes in the entire neutrophil population was elevated
in the control cows during the same period in which
the percentage of mature neutrophils was very low
and the percentage of band neutrophils was elevated.
Metamyelocytes were observed from d +2 to +6 in the
control cows and on d +6 in only 1 treated cow. In the
most severely diseased cow, 7% of the neutrophil
population was metamyelocytes versus 2% in the
other cows.
Cortisol
No differences between groups were observed. On d
0, plasma cortisol increased in the control cows by
approximately 92% ( P < 0.05) (Figure 14). Between
30 and 72 h postinfection, normal concentrations were
observed. On d +3, cortisol increased ( P < 0.05) in
both groups followed by a return to normal preinfec-
tion values. When the cortisol concentration is
studied in detail during the first 72 h after infection,
a 1.6-fold increase is observed at 24 h postinfection in
the treated cows, and a 2.4-fold increase is observed
in the control cows.
a-LA
In the treated cows, there were no changes ( P >
0.05) in blood a-LA concentrations during the course
of the study because of extreme variability among
cows. a-Lactalbumin slightly increased after infection
to a maximum around 72 h after infection (Figure
15). The huge increase between d +6 and +28 was due
to 1 cow. If the results from this cow were omitted
(data not shown), the concentration between d +6
and +28 was only double the concentration before
infection.
In the control cows, blood a-LA increased ( P <
0.05) from 30 to 48 postinfection followed by a return
to normal values. However, this increase was due to 1
cow. If the data for this cow were omitted (data not
shown), no increase was observed. The concentra-
tions between d +6 and +28 were also higher ( P <
0.05) than preinfection concentrations and were
primarily due to 3 cows. The concentration between d
+6 and +9 was higher ( P < 0.01) than the concentra-
tion on d +3.
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Figure 14. Changes in the concentration of cortisol in the
plasma of recombinant bST-treated cows ( Ú) and control cows ( ×)
during experimentally induced Streptococcus uberis mastitis. Data
are means of five cows, and error bars represent the standard
errors of the means. Periods: ±1 = preinfection, 0 = 6 to 24 h after
infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection,
3 = 78 to 96 h after infection, 4 = d +6 to +9, and 5 = d +14 to +28.
Figure 15. Changes in the concentration of a-LA in the plasma
of recombinant bST-treated cows ( Ú) and control cows ( ×) during
experimentally induced Streptococcus uberis mastitis. Data are
means of five cows, and error bars represent the standard errors of
the means. Periods: ±1 = preinfection, 0 = 6 to 24 h after infection, 1
= 30 to 48 h after infection, 2 = 54 to 72 h after infection, 3 = 78 to
96 h after infection, 4 = d +6 to +9, and 5 = d +14 to +28.
When the first 72 h after infection are studied in
detail, a 3- and 8-fold increase was observed in blood
a-LA of the treated and control groups, respectively,
after 24 h. The concentration of a-LA in the treated
group returned to normal values by 36 h postinfec-
tion, and, in the control group, the concentration of a-
LA returned to normal by 48 h postinfection.
DISCUSSION
Treatment of cows with bST appeared to protect
cows from severe clinical symptoms during a subse-
quent episode of experimental S. uberis mastitis.
Previously treated cows had a reduced fever, and less
tachycardia, and the local symptoms, such as swell-
ing, pain, and firmness of the infected glands, were
also less pronounced. Protective effects on the
severity of general and local clinical symptoms during
mastitis have also been observed in cows suffering
from experimentally induced E. coli mastitis (49).
Cows that were classified as severe responders based
on the respiratory burst activity of their circulating
neutrophils (23, 50) and on differences in blood and
milk components prior to infection reacted as moder-
ate responders when treated with bST. These findings
could be ascribed to an enhancement of the rate of
diapedesis of neutrophils into the milk, to an in-
creased number of circulating mature and immature
neutrophils, and to an enhanced oxidative burst ac-
tivity of these neutrophils (49).
Indeed, ST primes human and rat monocytes, mac-
rophages, and neutrophils for enhanced production of
reactive oxygen species in vitro (10, 20, 52) and in
vivo (11, 19). In contrast to those results, Heyneman
and Burvenich (21) could not demonstrate any effect
on the respiratory burst of bovine neutrophils after
administration of bST in vitro. However, in vivo ad-
ministration of bST induced an enhancement of su-
peroxide production after stimulation with zymosan
or PMA in healthy cows and by zymosan only in cows
suffering from E. coli mastitis (21). The beneficial
effects of ST on immune cells might be accomplished
either directly or indirectly by the action of IGF-I.
Indeed, ST receptors have been identified on bovine
thymocytes, and IGF receptors have been detected on
peripheral blood mononuclear cells (55). In the
present study, administration of recombinantly der-
ived bST increased concentrations of bST in plasma
by approximately 34%. This response is consistent
with the results of others (8, 38, 51, 56).
Somatotropin also may increase concentrations of bST
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in milk (41, 56), although Miekle et al. (38) and
Eppard et al. (15) could not detect bST in milk. In
the present study, plasma concentrations of IGF-I
increased after bST administration, which is consis-
tent with the results of other studies (8, 38, 51, 56).
The concentration of IGF-I in milk has also been
reported to increase after bST injection (9, 56). Ac-
cording to Prosser et al. (41), this IGF-I originates
from the circulation, rather than being locally synthe-
sized de novo by mammary epithelial cells (6) . Con-
sequently, bST and IGF-I may influence the activity
of PMN and macrophages in milk. After infection,
plasma IGF-I significantly decreased, especially in
the control cows, and plasma bST remained practi-
cally unchanged. Gene expression of IGF-I is mainly
controlled by ST in hepatic and nonhepatic tissues,
but glucocorticosteroids, neuropeptides, estrogens,
and cytokines may also regulate IGF-I transcription
(1) . The interaction of these regulators may be in-
volved in the decreased IGF-I concentration in the
control cows. Because of this decreased concentration,
the beneficial effects of basal bST, and especially IGF-
I, on neutrophils and macrophages might be less
pronounced in the control cows, which may explain
the more severe illness in these cows. Unlike E. coli
mastitis, the macrophage is the most important im-
mune cell in the defense against S. uberis (24).
Treatment with bST had little effect on the CL
response of circulating PMN after stimulation by
PMA or latex beads, which is in contrast to the find-
ings of Heyneman and Burvenich (21), Edwards et
al. (11), and Fu et al. (19). Total CL response
decreased shortly on d +4 followed by an increase to a
response that was higher than preinfection responses.
The CL response after stimulation of PMN by PMA
was more suppressed than the CL response after
stimulation by latex. Phorbol 12-myristate 13-acetate
directly stimulates the respiratory burst by activating
protein kinase C without being internalized. In con-
trast, latex beads nonspecifically adhere to the phago-
cyte surface by electrostatic and hydrophobic forces.
Consequently, they are internalized within the phago-
cyte, which then activates the respiratory burst. No
opsonization is necessary, and no complement or Fc
receptors on the phagocytes are involved. Based on
this difference, the results indicate that the respira-
tory burst is depressed, and phagocytosis is un-
affected or possibly stimulated. The phagocytic ability
of the PMN was probably less affected or not affected
during infection. Indeed, the expression of CD11b or
complement receptor 3, which binds the opsonic com-
plement factor 3b, was upregulated after infection in
our study, which might indicate that CD11b-mediated
phagocytosis is increased, as perhaps is nonspecific
phagocytosis. We also observed that the corrected CL
response showed an increasing trend and no
decreases, which is in contrast with the total CL
response. This decrease coincided with a decrease in
the number of circulating WBC and circulating ma-
ture neutrophils, but an increase of the number of
circulating immature neutrophils that had an im-
paired activity. This pattern is consistent with a
greater depression in the burst activity of eosinophils
compared with that of the neutrophils. However, by
the end of the trial, CL responses exceeded normal
baseline responses. These elevated responses coin-
cided with an increase in the number of circulating
mature neutrophils. This increased CL response may
be due to a priming effect by endogenous inflamma-
tory mediators and hormones on phagocytes released
from bone marrow. Inflammatory mediators could
then stimulate the neutrophils released from the bone
marrow and prime them for an enhanced production
of reactive oxygen species. Similar findings have been
reported during acute coliform mastitis (23). En-
hanced CL responses were more pronounced in bST-
treated cows, which might suggest that, in addition to
the influence of inflammatory mediators, the elevated
blood concentrations of bST and IGF-I favored the
proliferation and generation of PMN that were
primed for an increased burst activity. Fu et al. (20)
and Bjerknes and Aarskog ( 4 ) reported priming of
human neutrophils by IGF-I and ST for superoxide
secretion after stimulation with PMA. Priming of hu-
man neutrophils by interleukin-1, interleukin-8,
tumor necrosis factor-a ( TNF-a) , CD18 cross-linking,
and IGF-I has been reported (12, 18, 34, 54). Bovine
neutrophils have been shown to be primed by
interleukin-1, interleukin-2, and TNF-a (43).
Insulin-like growth factor-I also stimulates the
production of TNF-a (42) and granulocyte-
macrophage colony-stimulating factor (44) by mono-
cytes and macrophages.
In vivo bST treatment did not affect diapedesis of
PMN across a monolayer of secretory epithelial cells
in vitro in the present study. Diapedesis decreased
after infection and returned to baseline values at 3
wk after infection in both groups.
No effect of bST was observed on the expression of
CD11a on PMN. The down-regulation of CD11a,
although of only minor importance, may be partly
responsible for the decreased diapedesis because
CD11a was shown to be essential for C5a-induced
leukocyte adherence in rabbits (3) . The expression of
CD11b was not affected by bST treatment. In hu-
mans, however, upregulation of CD11b on PMN by
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IGF-I has been reported (4) .
Because the removal of S. uberis from the mam-
mary gland is mainly dependent on macrophages
rather than neutrophils, the absence of significant
effects of bST on neutrophil functions is not detrimen-
tal for the outcome of this kind of mastitis, which is in
contrast with coliform mastitis. Recombinant bST
treatment may affect macrophage and monocyte func-
tions, which were not studied in this experiment.
Treatment with bST protected the cows from exces-
sive leukopenia. The effect may be due to the lower
migration of PMN from blood to milk, expressed as a
lower SCC in the treated cows (25), or to an in-
creased myelopoiesis induced by ST and IGF-I (37,
39, 40, 44).
Treatment with bST had no effect on the number of
circulating lymphocytes. The higher number of cir-
culating mature neutrophils in the treated group may
be due to stimulatory effects of IGF-I on bone marrow
(7) . The percentage of circulating mature neutrophils
increased in both groups, especially in the bST-
treated cows. This pattern may be partially due to
cortisol. Indeed, intravenous injection of hydrocorti-
sone induces a release of young reserve neutrophils
from the bone marrow (48). The larger number of
circulating immature neutrophils (band neutrophils
and metamyelocytes) in the control cows, was proba-
bly due to the more severe leukopenia and the higher
SCC in these cows. In general, no important effects of
bST treatment on the number of mature cells could be
observed, which is consistent with the results of other
studies (5, 14, 16). Hematocrit significantly de-
creased in the treated cows (data not shown), which
is also consistent with the same studies.
The increase of a-LA in plasma between 30 and 48
h postinfection in the control cows indicated severe
damage of the epithelial cell tight junctions of the
blood-milk barrier. The changes in milk lactose, BSA,
Na+, K+, and Cl± are also indicative of this damage
(25). In the treated cows, no significant changes were
observed, perhaps indicating some protection of the
blood-milk barrier by bST. The increase in the bST-
treated cows was due to only 1 cow, the most severely
diseased cow of that group. This cow was still very ill,
milk lactose concentration was still very low, and the
SCC, CL±, and Na+ were still very high, although the
milk concentration of BSA had already decreased.
Differences in molecular mass and in rates of diffu-
sion and secretory rate are responsible for the differ-
ence in leakage of BSA and lactose. The elevated
blood concentration of a-LA implies that repair of
tight junctions was occurring but was not complete.
The huge increase of blood a-LA in the control group
was due to 3 cows, which were again, the most se-
verely diseased. The elevated concentration of a-LA
indicated that the damaged blood-milk barrier was
still incompletely repaired, which was also concluded
earlier by Hoeben et al. (25). The concentration of a-
LA in serum is the reflection of two processes: first,
the integrity of mammary epithelial tight junctions.
The more leaky these junctions are, the more a-LA
can escape into the circulation. The second process is
the rate of secretion of milk, which affects not only
the amount of a-LA that can diffuse across the
epithelium, but also the intramammary pressure. In-
creased intramammary pressure increases the flow of
a-LA into blood; conversely, decreased intramammary
pressure decreases flow of milk components, such as
a-LA, into blood. We did not observe a larger increase
in blood a-LA during the initial, acute stages of the
infection because milk production was dramatically
decreased (25) along with intramammary pressure.
From d +6, a-LA in serum was elevated because
secretory rate (milk production) had almost reco-
vered, but there was still damage to the mammary
gland and the epithelial tight junctions. Measuring
the concentration of a milk-specific protein such as a-
LA in blood will always be a more sensitive measure
of mammary damage than measuring blood compo-
nents in milk, or the ratio of K+ to Na+, or milk
lactose concentrations, because the high secretory
rate during the chronic phase of the infection tends to
mask the effect on milk composition.
In conclusion, the beneficial effects of bST on
general and local clinical symptoms during ex-
perimentally induced S. uberis mastitis are not due to
positive effects on the function of neutrophils, as sug-
gested by Vandeputte-Van Messom and Burvenich
(49) for E. coli mastitis. The neutrophil function of
cows previously treated with bST was not improved
compared with the control cows. The positive effect of
bST is probably due to a protective effect on the blood-
milk barrier and possibly to an increased elimination
of the infection. As a consequence, fewer inflamma-
tory mediators are released, which positively affects
the general and local symptoms.
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